Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John K. Cini currently holds 14,116 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John K. Cini has been a net neutral trader of SONN stock. They have purchased $0 and sold $0 worth of shares.
John K. Cini's most recent insider trade was on Dec 2, 2025, when they sold 14,116 shares at $0.00 per share.
John K. Cini serves as Executive at Sonnet BioTherapeutics Holdings, Inc. (SONN). They have executed 9 insider transactions totaling $0 over their tenure at the company.
John K. Cini holds the position of Executive at Sonnet BioTherapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
John K. Cini has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John K. Cini was on May 25, 2021, when they sold $21.1K worth of SONN shares. This transaction involved 14,004 shares at $1.51 per share.
John K. Cini currently owns 14,116 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John K. Cini's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John K. Cini has 9 Form 4 filings on record as an insider at Sonnet BioTherapeutics Holdings, Inc..
Set alerts for John K. Cini and 40,000+ other insiders.